Tag: Johns Hopkins University School of Medicine

acalabrutinib

Cancer Drug Shows Promise as Treatment for Food Allergies

A study published in the Journal of Allergy and Clinical Immunology shows acalabrutinib, a BTK inhibitor, can reduce and prevent allergic reactions to peanuts...
Xolair (omalizumab)

Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3...

Assessment for both single agent and add-on therapy.
Test Tubes

FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...

Phase 2 study of candidate from Aravax will commence in the US and Australia.
Cow

Baked Milk OIT May Help Kids with Severe Cow’s Milk Allergy

Promising treatment for children with severe allergy to cow's milk.
SUNBEAM babyfoot

NIH Study of Early Predictors, Mechanisms of Food Allergy and Eczema...

Study to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis as well as biological pathways that lead to these conditions.
COVID-19 Vaccine

NIH Rushing to Find Cause of Rare Allergic Reactions to COVID-19...

"This is not a simple study design. We expect to be looking at highly allergic individuals. They will be not necessarily so easy to recruit, either."
Eggs

Egg Oral Immunotherapy Could be Better Option than Baked Egg Therapy...

5 year multi-site study shows egg OIT was significantly more likely to achieve sustained unresponsiveness compared to children opting for baked egg therapy.